Fritextsökning
Innehållstyper
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Google och Abbvie i miljardsamarbete
Googles spinoff-bolag Calico ingår ett samarbete med läkemedelsjätten Abbvie.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
"Konsulter ger oss nya perspektiv"
Pernilla Sandwall, Chief Operating Officer på Index Pharmaceutcals, berättade på Life Science Swedens event Pharma Outsourcing om bolagets modell för outsourcing.
-
Stort intresse för New Horizons
Just nu pågår livesändningen av Life Science Swedens event New Horizons in Biologics & Bioprocessing – och intresset är rekordstort.
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
Young, bright and committed to labtech
Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...
-
Diagnostics to deal with new diseases
Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...
-
Scilifelab får ny site-chef
Utser ny ansvarig för forskningscentrets verksamhet i Stockholm.
-
Tom Britton: ”Nivån för flockimmunitet är lägre än vad vi trott”
Nya matematiska modeller pekar på att flockimmunitetsnivån är kraftigt lägre än vad man tidigare trott, och att immuniteten i dagsläget spelar en större roll, e...
-
Näthandeln är en stor utmaning för småföretagarna
Att sätta upp en webbshop är enkelt idag. Men att ranka högt på Google är betydligt svårare.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Unga forskare prisas
Upptäckt koppling mellan tarmfloran och fetma belönas när pris för unga forskare delas ut i Stockholm.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Väntar sig patent
Follicum får preliminärt godkännande från Europapatentverket.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.